Literature DB >> 31163125

Hypoxia differentially regulates estrogen receptor alpha in 2D and 3D culture formats.

Nathan A Whitman1, Zhi-Wei Lin1, Rachael M Kenney1, Leonardo Albertini1, Matthew R Lockett2.   

Abstract

Hypoxia is a common feature in solid tumors. Clinical samples show a positive correlation between the expression of the hypoxia-inducible factor HIF-1α and estrogen receptor alpha (ERα) and a negative correlation between HIF-1α and hormone sensitivity. Results from monolayer cultures are in contention with clinical observations, showing that ER (+) cell lines no longer express ERα under hypoxic conditions (1% O2). Here, we compared the impact of hypoxia on the ERα signaling pathway for T47D cells in a 2D and 3D culture format. In the 2D format, the cells were cultured as monolayers. In the 3D format, paper-based scaffolds supported cells suspended in a collagen matrix. Using ELISA, Western blot, and immunofluorescence measurements, we show that hypoxia differentially regulates ERα protein levels in a culture environment-dependent manner. In the 2D format, the protein levels are significantly decreased in hypoxia. In the 3D format, the protein levels are maintained in hypoxia. Hypoxia reduced ERα transcriptional activation in both culture formats. These results highlight the importance of considering tissue dimensionality for in vitro studies. They also show that ERα protein levels in hypoxia are not an accurate indicator of ERα transcriptional activity, and confirm that a positive stain for ERα in a clinical sample may not necessarily indicate hormone sensitivity.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; Estrogen signaling; Hypoxia-inducible factor (HIF)

Mesh:

Substances:

Year:  2019        PMID: 31163125      PMCID: PMC6688900          DOI: 10.1016/j.abb.2019.05.025

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  73 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  HIF-1 and mechanisms of hypoxia sensing.

Authors:  G L Semenza
Journal:  Curr Opin Cell Biol       Date:  2001-04       Impact factor: 8.382

3.  Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.

Authors:  Reinhard Bos; Petra van der Groep; Astrid E Greijer; Avi Shvarts; Sybren Meijer; Herbert M Pinedo; Gregg L Semenza; Paul J van Diest; Elsken van der Wall
Journal:  Cancer       Date:  2003-03-15       Impact factor: 6.860

4.  Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis.

Authors:  R Bos; H Zhong; C F Hanrahan; E C Mommers; G L Semenza; H M Pinedo; M D Abeloff; J W Simons; P J van Diest; E van der Wall
Journal:  J Natl Cancer Inst       Date:  2001-02-21       Impact factor: 13.506

5.  Proteasome-mediated proteolysis of estrogen receptor: a novel component in autologous down-regulation.

Authors:  E T Alarid; N Bakopoulos; N Solodin
Journal:  Mol Endocrinol       Date:  1999-09

6.  Intermittent hypoxia induces proteasome-dependent down-regulation of estrogen receptor alpha in human breast carcinoma.

Authors:  Charlton Cooper; Guang-Yu Liu; Yu-Lian Niu; Sylvia Santos; Leigh C Murphy; Peter H Watson
Journal:  Clin Cancer Res       Date:  2004-12-15       Impact factor: 12.531

7.  Cobalt chloride-induced estrogen receptor alpha down-regulation involves hypoxia-inducible factor-1alpha in MCF-7 human breast cancer cells.

Authors:  Jungyoon Cho; Dukkyung Kim; SeungKi Lee; YoungJoo Lee
Journal:  Mol Endocrinol       Date:  2005-02-03

8.  CHIP (carboxyl terminus of Hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptor-alpha.

Authors:  Meiyun Fan; Annie Park; Kenneth P Nephew
Journal:  Mol Endocrinol       Date:  2005-07-21

9.  Hypoxia induces proteasome-dependent degradation of estrogen receptor alpha in ZR-75 breast cancer cells.

Authors:  Matthew Stoner; Bradley Saville; Mark Wormke; Dana Dean; Robert Burghardt; Stephen Safe
Journal:  Mol Endocrinol       Date:  2002-10

10.  Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists.

Authors:  Vickie S Wilson; Kathy Bobseine; L Earl Gray
Journal:  Toxicol Sci       Date:  2004-05-27       Impact factor: 4.849

View more
  4 in total

1.  Three dimensional engineered models to study hypoxia biology in breast cancer.

Authors:  Vaishali Aggarwal; Oshin Miranda; Paul A Johnston; Shilpa Sant
Journal:  Cancer Lett       Date:  2020-06-20       Impact factor: 8.679

2.  Hypoxia alters the release and size distribution of extracellular vesicles in pancreatic cancer cells to support their adaptive survival.

Authors:  Mary C Patton; Haseeb Zubair; Mohammad Aslam Khan; Seema Singh; Ajay P Singh
Journal:  J Cell Biochem       Date:  2019-08-12       Impact factor: 4.429

3.  Developing a Drug Screening Platform: MALDI-Mass Spectrometry Imaging of Paper-Based Cultures.

Authors:  Fernando Tobias; Julie C McIntosh; Gabriel J LaBonia; Matthew W Boyce; Matthew R Lockett; Amanda B Hummon
Journal:  Anal Chem       Date:  2019-12-06       Impact factor: 6.986

4.  Dual effects of hypoxia on proliferation and osteogenic differentiation of mouse clonal mesenchymal stem cells.

Authors:  Hyoungki Kim; Soonjo Kwon
Journal:  Bioprocess Biosyst Eng       Date:  2021-04-05       Impact factor: 3.210

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.